Drug class

Results: 489



#Item
401Health / Pharmacology / Clinical pharmacology / Therapeutics / United States Public Health Service / Medical device / Class I recall / Medicine / Food and Drug Administration / Pharmaceutical sciences

Microsoft Word[removed]CP[removed]Att E February[removed]Final.doc

Add to Reading List

Source URL: www.fda.gov

Language: English
402Penology / Traffic law / Crimes / Vehicular homicide / Felony / Indefinite imprisonment / 10-20-Life / Law / Criminal law / Manslaughter

RESENTENCING ELIGIBILITY (2009): CALCULATING THE 10 YEAR LOOK BACK SIMPLIFIED Class B Drug Offense Resentence - CPL § [removed]Determining the 10 Year Look Back Period Step 1: Calculate the period of time between the date

Add to Reading List

Source URL: www.communityalternatives.org

Language: English - Date: 2011-01-25 07:06:52
403Health / Viral load / Antiretroviral drug / Assay / Medical device / Food and Drug Administration / HIV / Didanosine / Zidovudine / Medicine / Chemistry / HIV/AIDS

Guidance for Industry Class II Special Controls Guidance Document: In Vitro HIV Drug Resistance Genotype Assay Additional copies of this guidance are available from the Office of Communication, Outreach

Add to Reading List

Source URL: www.fda.gov

Language: English
404State court / Stuart Rabner / Class action / New Jersey Supreme Court

NOTICE TO THE BAR MASS TORTS – TERMINATION OF CENTRALIZED MANAGEMENT OF LITIGATION INVOLVING THE DRUG ZELNORM In accordance with Court Rule 4:38A and the Revised Mass Tort Guidelines as promulgated by Directive #7-09,

Add to Reading List

Source URL: www.judiciary.state.nj.us

Language: English - Date: 2011-11-18 14:09:01
405Class action / Clopidogrel / State court / Chemistry / Organic chemistry / Civil law

NOTICE TO THE BAR PROPOSED TERMINATION OF CENTRALIZED MANAGEMENT OF NEW JERSEY STATE COURT LITIGATION INVOLVING THE DRUG PLAVIX By Order dated July 12, 2011, the Supreme Court assigned all New Jersey statecourt litigatio

Add to Reading List

Source URL: www.judiciary.state.nj.us

Language: English - Date: 2011-11-10 14:04:56
406Food and Drug Administration / Medical device / Medical equipment / Medical technology / Premarket approval / Separator / Apheresis / Blood donation / Federal Food /  Drug /  and Cosmetic Act / Medicine / Transfusion medicine / Hematology

Class II Special Controls Guidance Document: Automated Blood Cell Separator Device Operating by Centrifugal or Filtration Separation Principle

Add to Reading List

Source URL: www.fda.gov

Language: English
407Food and Drug Administration / Medical device / Medical equipment / Medical technology / Premarket approval / Separator / Apheresis / Blood donation / Federal Food /  Drug /  and Cosmetic Act / Medicine / Transfusion medicine / Hematology

Class II Special Controls Guidance Document: Automated Blood Cell Separator Device Operating by Centrifugal or Filtration Separation Principle

Add to Reading List

Source URL: www.fda.gov

Language: English
408Medicine / Food and Drug Administration / Epidemiology / Therapeutics / United States Public Health Service / Center for Drug Evaluation and Research / Pharmacovigilance / National Institute on Drug Abuse / Health / Pharmaceutical sciences / Pharmacology

Public Meeting on the Postmarketing Requirements for the Class-Wide Extended-Release/Long-Acting Opioid Analgesics May 19-20, 2014 Agenda __________________________________________________________________________________

Add to Reading List

Source URL: www.fda.gov

Language: English
409Food and Drug Administration / Clinical pharmacology / Pharmacology / Therapeutics / United States Public Health Service / Food Safety and Inspection Service / Product recall / Recall / Class I recall / Pharmaceutical sciences / Food and drink / Clinical research

AFDO RECALL SURVEY 2010 In response to the question “What challenges or obstacles were experienced by your agency in coordinating these recalls”, state agencies indicated the following: • • •

Add to Reading List

Source URL: www.afdo.org

Language: English - Date: 2011-11-30 11:44:47
410Opioid / Analgesic / Pharmaceutical industry / Food and Drug Administration / Pharmaceutical sciences / Pharmacology / Clinical research

FDA Public Meeting Postmarketing Requirements for the Class-Wide Extended-Release/Long-Acting Opioid Analgesics Participant Disclosure Form May 19-20, 2014 Dear Participant:

Add to Reading List

Source URL: www.fda.gov

Language: English
UPDATE